PolyQuant

PolyQuant

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PolyQuant is a specialized proteomics service and product company based in Bad Abbach, Germany. It leverages its proprietary QconCAT technology to offer absolute protein quantification services and ready-to-use kits for research and clinical applications. The company serves both academic and industrial clients, focusing on biomarker research, clinical proteomics, and the development of mass spectrometry-based diagnostics. Its business model combines fee-for-service work with the sale of standardized assay kits.

Cardiovascular DiseasesInfectious Diseases

Technology Platform

QconCAT (Quantification conCATamer) technology for absolute protein quantification via mass spectrometry. Platform includes custom design services and ready-to-use kits of peptide/protein standards.

Opportunities

The growing shift from immunoassays to mass spectrometry for protein quantification in both research and clinical diagnostics presents a major opportunity.
The need for multiplexed, absolute quantification of protein panels for complex diseases aligns perfectly with PolyQuant's core QconCAT technology.
Expanding partnerships with diagnostic companies could accelerate the path to market for regulated IVD tests.

Risk Factors

Intense competition from larger mass spectrometry vendors and alternative proteomic technologies threatens market share.
The slow, costly, and complex regulatory pathway for clinical diagnostics limits the near-term commercialization of their kits.
As a smaller private company, resource constraints could hinder large-scale R&D and commercial expansion.

Competitive Landscape

PolyQuant competes in the proteomics services and products space against large instrument manufacturers (Thermo Fisher, Bruker, Sciex) who offer integrated quantification solutions, numerous academic and commercial core labs providing similar services, and companies offering alternative high-plex protein measurement platforms (e.g., Olink, SomaScan). Its differentiation lies in its deep specialization in the QconCAT method for absolute quantification.